| Source: |
| Type: |
| CTSD — Cathepsin D Primary role: Lysosomal aspartyl protease; regulator of autophagic degradation and stress-adaptive survival signaling. Cancer relevance: CTSD supports lysosomal proteolysis and autophagic completion, enabling metabolic recycling under stress. In cancer, it is often overexpressed and can function both intracellularly (autophagy, apoptosis modulation) and extracellularly (growth factor processing). Partial lysosomal leakage of CTSD contributes to apoptotic signaling, while intact activity promotes therapy resistance. Net effect in established cancer: Predominantly pro-survival via maintenance of autophagic flux, with pro-apoptotic potential under severe stress. |
| 5173- | Ash, | 2DG, | Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 | - | in-vitro, | BC, | T47D |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1430 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid